National Institute of Neurological Disorders and Stroke Notice of Meeting, 12859-12860 [2012-5037]
Download as PDF
Federal Register / Vol. 77, No. 42 / Friday, March 2, 2012 / Notices
Time: 10 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jose H Guerrier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–435–
1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Digestive Sciences.
Date: March 26, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Bonnie L. Burgess-Beusse,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182,
MSC 7818, Bethesda, MD 20892, 301–435–
1783, beusseb@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Pilot and
Feasibility Clinical Research Studies in
Digestive Diseases and Nurtrition
Date: March 26, 2012.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Peter J Perrin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, (301) 435–
0682, perrinp@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
National Institute of Neurological
Disorders and Stroke Notice of
Meeting
The meeting will feature invited
speakers and discussion of committee
business items including a report on the
findings of the Institute of Medicine
report Relieving Pain in America: A
Blueprint for Transforming Prevention,
Care, Education, and Research and a
review of information gathered on
federally-funded pain research.
The meeting will be open to the
public and accessible by live webcast
and conference call.
Name of Committee: Interagency Pain
Research Coordinating Committee.
Type of meeting: Open Meeting.
Date: March 27, 2012.
Time: 8:30 a.m. to 4:30 p.m. *Eastern
Time*—Approximate end time.
Agenda: The meeting will feature
invited speakers and discussion of
committee business items including a
report on the findings of the Institute of
Medicine report Relieving Pain in
America: A Blueprint for Transforming
Prevention, Care, Education, and
Research and a review of information
gathered on federally-funded pain
research.
Place: National Institutes of Health,
Building 1, Wilson Hall, 1 Center Drive,
Bethesda, MD 20892.
Conference Call: Dial: 800–779–1482,
Participant Passcode: 31855.
Cost: The meeting is free and open to
the public.
Webcast Live https://videocast.nih.
gov/.
Registration: https://iprcc.nih.gov/.
Pre-registration is recommended to
expedite check-in. Seating in the
meeting room is limited to room
capacity and is on a first come, first
served basis.
Deadlines: Notification of intent to
present oral comments: Friday, March
16, 2012, by 5 p.m. ET
Submission of written/electronic
statement for oral comments: Tuesday,
March 20, 2012, by 5 p.m. ET
Submission of written comments:
Thursday, March 22, 2012, by 5 p.m. ET
Access: Medical Center Metro (Red
Line) Visitor Information: https://
www.nih.gov/about/visitor/index.htm.
Contact Person: Dr. Paul Scott,
Director, Office of Science Policy and
Planning, National Institute of
Neurological Disorders and Stroke, NIH,
31 Center Drive, Room 8A03, Bethesda,
MD 20892, Phone: (301) 496–9271,
Email: IPRCC
PublicInquiries@mail.nih.gov.
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of an Interagency Pain
Research Coordinating Committee
(IPRCC) meeting.
Please Note: Any member of the public
interested in presenting oral comments to the
Committee must notify the Contact Person
listed on this notice by 5 p.m. ET on Friday,
March 16, 2012, with their request to present
oral comments at the meeting. Interested
individuals and representatives of
Dated: February 24, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–5046 Filed 3–1–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
tkelley on DSK3SPTVN1PROD with NOTICES
National Institutes of Health
VerDate Mar<15>2010
18:58 Mar 01, 2012
Jkt 226001
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
12859
organizations must submit a written/
electronic copy of the oral statement/
comments including a brief description of the
organization represented by 5 p.m. ET on
Tuesday, March 20, 2012.
Statements submitted will become a
part of the public record. Only one
representative of an organization will be
allowed to present oral comments on
behalf of that organization, and
presentations will be limited to three to
five minutes per speaker, depending on
number of speakers to be accommodated
within the allotted time. Speakers will
be assigned a time to speak in the order
of the date and time when their request
to speak is received, along with the
required submission of the written/
electronic statement by the specified
deadline. If special accommodations are
needed, please email the Contact Person
listed above.
In addition, any interested person
may submit written comments to the
IPRCC prior to the meeting by sending
the comments to the Contact Person
listed on this notice by 5 p.m. ET,
Thursday, March 22, 2012. The
comments should include the name
and, when applicable, the business or
professional affiliation of the interested
person. All written comments received
by the deadlines for both oral and
written public comments will be
provided to the IPRCC for their
consideration and will become part of
the public record. The meeting will be
open to the public through a conference
call phone number and webcast live on
the Internet. Members of the public who
participate using the conference call
phone number will be able to listen to
the meeting but will not be heard. If you
experience any technical problems with
the conference call or webcast, please
call Operator Service on 301 496–4517
for conference call issues and the NIH
IT Service Desk at (301) 496–4357, toll
free (866) 319–4357, for webcast issues.
Individuals who participate in person
or by using these electronic services and
who need special assistance, such as
captioning of the conference call or
other reasonable accommodations,
should submit a request to the Contact
Person listed on this notice at least
seven days prior to the meeting.
As a part of security procedures,
attendees should be prepared to present
a photo ID during the security process
to get on the NIH campus. For a full
description, please see: https://
www.nih.gov/about/visitorsecurity.htm.
Pre-registration is recommended.
Seating will be limited to the room
capacity and seats will be on a first
come, first served basis, with expedited
check-in for those who are preregistered.
E:\FR\FM\02MRN1.SGM
02MRN1
12860
Federal Register / Vol. 77, No. 42 / Friday, March 2, 2012 / Notices
Information about the IPRCC is
available on the Web site: https://
iprcc.nih.gov/.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: February 24, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy .
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
[FR Doc. 2012–5037 Filed 3–1–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meetings
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Autism Centers of
Excellence: Centers.
Date: March 28–29, 2012.
Time: 7:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Cathy J. Wedeen, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, OD, Eunice Kennedy
Shriver National Institute of Child Health
And Human Development, NIH, 6100
Executive Blvd., Room 5B01–G, Bethesda,
MD 20892, 301–435–6878,
wedeenc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: February 24, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–5031 Filed 3–1–12; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
17:01 Mar 01, 2012
Jkt 226001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, NIDDK.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
NATIONAL INSTITUTE OF DIABETES
AND DIGESTIVE AND KIDNEY
DISEASES, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Board of Scientific
Counselors, NIDDK.
Date: April 5–6, 2012.
Time: April 5, 2012, 8:30 a.m. to 3:15 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 10, 10 Center Drive, Conference
Room 9S235, Bethesda, MD 20892.
Time: April 6, 2012, 8:30 a.m. to 3:15 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 10, 10 Center Drive, Conference
Room 9S235, Bethesda, MD 20892.
Contact Person: James E. Balow, MD,
Clinical Director, National Institute of
Diabetes and Digestive and Kidney Diseases,
National Institutes of Health, Building 10,
Room 9N222, Bethesda, MD 20892–1818,
301–496–4181, jimb@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: February 24, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–5018 Filed 3–1–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Maternal and Child
Health in Poor Countries: Evidence from
Randomized Evaluations MIT.
Date: March 19, 2012.
Time: 2 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Carla T. Walls, Ph.D.,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD
20892–7510, 301–435–6898,
wallsc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
E:\FR\FM\02MRN1.SGM
02MRN1
Agencies
[Federal Register Volume 77, Number 42 (Friday, March 2, 2012)]
[Notices]
[Pages 12859-12860]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-5037]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of an Interagency Pain
Research Coordinating Committee (IPRCC) meeting.
The meeting will feature invited speakers and discussion of
committee business items including a report on the findings of the
Institute of Medicine report Relieving Pain in America: A Blueprint for
Transforming Prevention, Care, Education, and Research and a review of
information gathered on federally-funded pain research.
The meeting will be open to the public and accessible by live
webcast and conference call.
Name of Committee: Interagency Pain Research Coordinating
Committee.
Type of meeting: Open Meeting.
Date: March 27, 2012.
Time: 8:30 a.m. to 4:30 p.m. *Eastern Time*--Approximate end time.
Agenda: The meeting will feature invited speakers and discussion of
committee business items including a report on the findings of the
Institute of Medicine report Relieving Pain in America: A Blueprint for
Transforming Prevention, Care, Education, and Research and a review of
information gathered on federally-funded pain research.
Place: National Institutes of Health, Building 1, Wilson Hall, 1
Center Drive, Bethesda, MD 20892.
Conference Call: Dial: 800-779-1482, Participant Passcode: 31855.
Cost: The meeting is free and open to the public.
Webcast Live https://videocast.nih.gov/ gov/.
Registration: https://iprcc.nih.gov/. Pre-registration is
recommended to expedite check-in. Seating in the meeting room is
limited to room capacity and is on a first come, first served basis.
Deadlines: Notification of intent to present oral comments: Friday,
March 16, 2012, by 5 p.m. ET
Submission of written/electronic statement for oral comments:
Tuesday, March 20, 2012, by 5 p.m. ET
Submission of written comments: Thursday, March 22, 2012, by 5 p.m.
ET
Access: Medical Center Metro (Red Line) Visitor Information: https://www.nih.gov/about/visitor/index.htm.
Contact Person: Dr. Paul Scott, Director, Office of Science Policy
and Planning, National Institute of Neurological Disorders and Stroke,
NIH, 31 Center Drive, Room 8A03, Bethesda, MD 20892, Phone: (301) 496-
9271, Email: IPRCC PublicInquiries@mail.nih.gov.
Please Note: Any member of the public interested in presenting
oral comments to the Committee must notify the Contact Person listed
on this notice by 5 p.m. ET on Friday, March 16, 2012, with their
request to present oral comments at the meeting. Interested
individuals and representatives of organizations must submit a
written/electronic copy of the oral statement/comments including a
brief description of the organization represented by 5 p.m. ET on
Tuesday, March 20, 2012.
Statements submitted will become a part of the public record. Only
one representative of an organization will be allowed to present oral
comments on behalf of that organization, and presentations will be
limited to three to five minutes per speaker, depending on number of
speakers to be accommodated within the allotted time. Speakers will be
assigned a time to speak in the order of the date and time when their
request to speak is received, along with the required submission of the
written/electronic statement by the specified deadline. If special
accommodations are needed, please email the Contact Person listed
above.
In addition, any interested person may submit written comments to
the IPRCC prior to the meeting by sending the comments to the Contact
Person listed on this notice by 5 p.m. ET, Thursday, March 22, 2012.
The comments should include the name and, when applicable, the business
or professional affiliation of the interested person. All written
comments received by the deadlines for both oral and written public
comments will be provided to the IPRCC for their consideration and will
become part of the public record. The meeting will be open to the
public through a conference call phone number and webcast live on the
Internet. Members of the public who participate using the conference
call phone number will be able to listen to the meeting but will not be
heard. If you experience any technical problems with the conference
call or webcast, please call Operator Service on 301 496-4517 for
conference call issues and the NIH IT Service Desk at (301) 496-4357,
toll free (866) 319-4357, for webcast issues.
Individuals who participate in person or by using these electronic
services and who need special assistance, such as captioning of the
conference call or other reasonable accommodations, should submit a
request to the Contact Person listed on this notice at least seven days
prior to the meeting.
As a part of security procedures, attendees should be prepared to
present a photo ID during the security process to get on the NIH
campus. For a full description, please see: https://www.nih.gov/about/visitorsecurity.htm.
Pre-registration is recommended. Seating will be limited to the
room capacity and seats will be on a first come, first served basis,
with expedited check-in for those who are pre-registered.
[[Page 12860]]
Information about the IPRCC is available on the Web site: https://iprcc.nih.gov/.
Dated: February 24, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy .
[FR Doc. 2012-5037 Filed 3-1-12; 8:45 am]
BILLING CODE 4140-01-P